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Abstract
Objectives The aim of the study was to clinically and his-
tologically evaluate the healing of human intrabony defects
treated with open flap surgery (OFD) and application of a
new, resorbable, fully synthetic, unsintered, nanocrystalline,
phase-pure hydroxyapatite (nano-HA).
Materials and methods Six patients, each of them display-
ing very advanced intrabony defects around teeth scheduled
for extraction due to advanced chronic periodontitis and
further prosthodontic considerations, were included in the
study. Following local anaesthesia, mucoperiosteal flaps
were reflected; the granulation tissue was removed, and
the roots were meticulously debrided by hand and ultrasonic
instruments. A notch was placed at the most apical extent of
the calculus present on the root surface or at the most apical
part of the defect (if no calculus was present) in order to
serve as a reference for the histological evaluation. Follow-
ing defect fill with nano-HA, the flaps were sutured by
means of mattress sutures to allow primary intention heal-
ing. At 7 months after regenerative surgery, the teeth were
extracted together with some of their surrounding soft and
hard tissues and processed for histological analysis.
Results The postoperative healing was uneventful in all
cases. At 7 months following surgery, mean PPD reduction
and mean CAL gain measured 4.0±0.8 and 2.5±0.8 mm,
respectively. The histological analysis revealed a healing
predominantly characterized by epithelial downgrowth.
Limited formation of new cementum with inserting connec-
tive tissue fibers and bone regeneration occurred in three out
of the six biopsies (i.e. 0–0.86 and 0–1.33 mm, respective-
ly). Complete resorption of the nano-HA was found in four
out of the six biopsies. A few remnants of the graft particles
(either surrounded by newly formed mineralized tissue or
encapsulated in connective tissue) were found in two out of
the six biopsies.
Conclusion Within their limits, the present results indicate
that nano-HA has limited potential to promote periodontal
regeneration in human intrabony defects.
Clinical relevance The clinical outcomes obtained follow-
ing surgery with OFD+nano-HA may not reflect true peri-
odontal regeneration.
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Introduction
Filling of periodontal defects with various types of bone
grafts is a widely employed technique aiming to restore the
lost periodontal attachment apparatus [1]. The use of certain
types of grafting materials such as intra- or extraoral autog-
enous bone grafts, demineralized freeze dried bone allograft
(DFDBA) or a natural bone mineral (NBM) has been shown
to result not only in substantial clinical improvements
evidenced by probing depth reduction, defect fill and
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clinical attachment gain but also to promote, at least to some
extent, formation of a new connective tissue attachment (i.e.
new cementum with inserting collagen fibres) and of new
alveolar bone [2–7]. The use of autogenous bone is limited
by its source, unpredictable resorption and increase in pa-
tient morbidity, while concerns have been expressed related
to the use of DFDBA and NBM related to their origin (i.e.
human and bovine) and the theoretical risk for immune-
mediated rejection of the graft and for transmission of
infectious diseases [8–10]. It was anticipated that the use
of synthetically produced bone substitute materials (i.e.
alloplasts) may circumvent the mentioned disadvantages of
autogenous, allogeneic or xenogeneic bone grafts [11]. The
currently available data indeed suggest that in intrabony
defects, the implantation of various types of alloplastic
grafts in conjunction with open flap debridement may lead
to significant improvements in the investigated clinical
parameters [12]. On the other hand, the available histolog-
ical evidence indicates that in human intrabony defects, the
healing following grafting with alloplastic grafts is predom-
inantly characterized by epithelial proliferation, connective
tissue encapsulation of the graft particles and limited peri-
odontal regeneration [13–19].
Recently, a new, fully synthetic, nanocrystalline, unsin-
tered, phase-pure hydroxyapatite (nano-HA) has been sug-
gested as a potential material for enhancing periodontal and
bone regeneration since its chemical composition and crys-
talline structure correspond to the calcium phosphate com-
ponent of natural bone and may have greater potential for
resorption compared with sintered hydroxyapatite [20–23].
Case series in the field of orthopaedic reconstructive surgery
have shown promising outcomes following nano-HA im-
plantation [22]. In the dental field, case reports have dem-
onstrated substantial clinical improvements following the
use of nano-HA for sinus and ridge augmentation, and
filling of peri-implant defects [23–25]. Furthermore, the
results of two randomized controlled clinical studies evalu-
ating the performance of nano-HA in intrabony periodontal
defects have indicated statistically significantly higher clin-
ical improvements following open flap debridement (OFD)
and subsequent defect fill with nano-HA compared to OFD
alone [26, 27].
Despite these promising results, to the best of our
knowledge, no data from human histological studies are
available on the healing of intrabony defects following
regenerative surgery with nano-HA. Thus, at the time
being, it is virtually unknown to what extent this grafting
material may promote periodontal wound healing/regen-
eration in humans.
Therefore, the aim of the present study was to evaluate
histologically the healing of human intrabony periodontal
defects treated with OFD and nano-HA.
Materials and methods
Subject population
The study protocol was designed and performed according
to the latest amendment of the Declaration of Helsinki
[http://www.wma.net/en/30publications/10policies/b3/] and
was approved by the Ethical Committee of Semmelweis
University, Budapest, Hungary (TUKEB 12/2005). Each
enrolled patient received verbal and written explanations
of the research protocol prior to signing the informed
consent form. Patients were recruited in the Department
of Periodontology, Semmelweis University, Budapest,
Hungary.
Six non-smoker patients (three females) with advanced
chronic periodontitis were included in the study. Each of
them participated with one advanced intrabony defect
around teeth scheduled for extraction due to advanced de-
struction of the periodontal attachment apparatus and further
prosthetic considerations. Each defect presented a probing
depth of at least 6 mm and an intrabony component of at
least 3 mm as visualized on the intraoral radiographs.
The selected teeth had some potential for periodontal
regeneration as diagnosed clinically and radiographically.
In every case, the decision to include the tooth in the study
was based upon agreement between two clinicians who
were not involved in the study.
All patients volunteered for the study and received verbal
and written information about its purpose and possible risks
and about the possibility to withdraw at any time. In every
case written informed consent was obtained prior to the start
of the study. The patients met the following inclusion crite-
ria: a) age between 20 and 70 years, b) completed initial
phase of periodontal therapy at least 6 weeks prior to sur-
gery, c) full mouth plaque scores (FMPS)≤20 % [28], d) full
mouth bleeding scores (FMBS)≤20 % [29], e) good com-
pliance to follow-up visits and self-performed oral hygiene,
f) legal ability to sign informed consent form, g) absence of
untreated endodontic lesion, and e) absence of hypermobil-
ity and occlusal overload. The exclusion criteria were a)
general medical history that contraindicates elective surgery
and may affect treatment outcome (e.g. uncontrolled diabe-
tes, osteoporosis, immunodeficiency), b) medication that
may affect treatment outcome (e.g. high dose steroid, hor-
mone replacement therapy, bisphosphonate, chemotherapy,
immunosuppressant), c) systemic antibiotic treatment within
3 months prior to the current study, e) pregnancy during the
experimental period, f) smoking within the past 5 years, g)
history of irradiation in head and neck region, and h) previ-
ous periodontal surgery at the selected site.
Three months before surgery, all patients received oral
hygiene instructions and full mouth supra- and subgingival
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scaling in order to reduce the soft tissue inflammation. In
order to reduce mobility when needed, the teeth were in-
cluded in temporary bridge reconstructions.
The following clinical parameters were assessed prior to
and 7 months after the surgical procedure using the same
type of periodontal probe (PCPUNC 15, Hu-Friedy, Chi-
cago, IL, USA): probing pocket depth (PPD) and clinical
attachment level (CAL) (Fig. 1a, e). Measurements were
rounded up to the nearest millimetre and were made at six
sites per tooth: mesiobuccal (mb), midbuccal (b), distobuc-
cal (db), mesiolingual (ml), midlingual (l) and distolingual
(dl) by a calibrated investigator (LL) who was not the same
as the surgeon. The cemento-enamel junction (CEJ) was
used as the reference point. In cases where the CEJ was
not visible, a restoration margin was used for these measure-
ments. The site presenting the central part of the defect was
included in the calculations. Calibration included CAL and
PPD measurements on five periodontal patients with similar
disease severity, but other than the patients enrolled in the
study. Data were captured from six sites per tooth from all
quadrants by the same way and same type of probe as de-
scribed above. Measurements were repeated alike, 90 min
apart. Calibration was accepted if at least 90% of the collected
figures were reproduced within a millimetre difference.
Standardized long cone radiographs were taken at base-
line and at biopsy removal, utilizing commercial plastic film
holder individualized by silicone putty impression material
(Fig. 1b, f) [30].
Reconstructive periodontal surgery
All surgeries were performed by the same experienced peri-
odontist (AH). Patients were asked to rinse with 0.2 %
chlorhexidine (Curasept ADS 220, Curaden, Kriens, Swit-
zerland) for 2 min just before perioral disinfection. In local
anaesthesia (articain 80 mg+epinephrine 0.024 mg; Ultra-
cain D-S forte, Aventis Pharma, Frankfurt am Main, Ger-
many) mucoperiosteal flaps were reflected bucally and
orally following intracrevicular incisions at the experimental
site plus one to two teeth apart. No releasing incisions were
deemed necessary. Granulation tissue was removed, and the
roots were meticulously debrided by means of hand and
ultrasonic instruments (Fig. 1c).
In all six defects, a notch was placed at the most apical
part of the defects using a small round bur (1-mm diameter).
In the presence of calculus, the notch would have been
placed at the most apical part of it as per study protocol.
Thus, any periodontal ligament tissue which later may de-
velop coronally to this notch on the root surface will be de
novo formed connective tissue and clearly distinguishable in
histological sections of biopsies. No root conditioning or
any other surface modifications were used.
During surgery, defect characteristics such as number of
bony walls and depth of the intrabony component were
recorded.
The intrabony defect was subsequently filled with the
nano-HA (Ostim®, Heraeus Kulzer, Hanau, Germany) paste
until the level of the alveolar crest, according to the manu-
facturer’s instruction (Fig. 1d). The mucoperiosteal flaps
were then repositioned and secured with suspended vertical
mattress sutures (non-resorbable, monofilament; Dafilon 5/
0, Braun Aesculap, Tuttlingen, Germany) in order to
achieve tension free flap closure.
Postoperative care
All patients were postoperatively administered antibiotics
(amoxicillin 500 mg+clavulanic acid 125 mg; Augmentin
675 mg, GlaxoSmithKline, Brentford, Middlesex, UK) three
times daily for 7 days and painkiller (Diclofenac 75 mg;
Diclofenac Duo, Pharmavit, Veresegyház, Hungary) accord-
ing to individual need. Subjects were advised not to brush
the surgical area but rinse with 0.2 % chlorhexidine two
times daily for 90 s during the following period of 4 weeks.
Sutures were removed at 14 days after surgery. The patients
resumed tooth cleaning with the use of a soft brush at
4 weeks post-surgery. Additional appointments including
oral hygiene instructions and with professional supragingi-
val tooth cleaning were performed fortnightly during the
first 12 postoperative weeks. After this period and until
biopsy removal, recall appointments were scheduled month-
ly. Neither subgingival instrumentation nor periodontal
probing was performed during the entire experimental peri-
od of 7 months.
Biopsy removal and histological processing
After a healing period of 7 months, the teeth were removed
together with some of their surrounding periodontal tissues
and immediately placed in 10 % buffered formalin for
fixation (Fig. 1g). Subsequently, the flaps were closed with
horizontal or vertical mattress sutures (Fig. 1h). The block
biopsies were fixed in 10 % buffered formalin, decalcified in
EDTA for a period of 4–6 weeks (depending on tooth/root
volume) and dehydrated in graded series of ethanol. Imme-
diately prior to embedding in paraffin, the roots/teeth were
split in two along their long axis either in buccooral or
mesiodistal direction (depending on the location of the
deepest site of the defect) exactly at the notch indicating
the deepest aspect of the intrabony defect (i.e. site of inter-
est). Thus, each biopsy provided two specimen blocks while
histological sections representing the deepest aspect of the
defect (prior to treatment) were obtained without the need
for extensive cutting. Twenty sections from each of the two
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blocks per specimen were obtained with the microtome
set at 8 μm and subsequently stained with hematoxylin–
eosin and the oxone-aldehyde-fuchsin-Halmi staining
method. On the section with the best technical quality,
one experienced examiner (AS) measured the following
parameters by means of a computer assisted toolbox,
while viewing the biopsies on an LCD flat screen with
live streaming of images, captured by a digital camera
(Olympus DP 71, Olympus Denmark AS, Ballerup,
Denmark) adapted to the light microscope (Olympus
DH 50, Olympus Denmark AS, Ballerup, Denmark): a)
cementum regeneration height: distance between apical
extension of the root planing and the coronal extension
of a continuous layer of new cementum or cementum-
like deposit on the planed root (millimetres), b) peri-
odontal ligament (PDL) regeneration height: distance
between apical extension of the root planing and the
coronal extension of a functionally oriented PDL on the
planed root (millimetres), c) bone regeneration height:
distance between the apical extension of root planing
and the coronal extension of regenerated alveolar bone
along the planed root (millimetres) (i.e. the coronal
extension of regenerated bone was defined as the most
coronal level where the periodontal ligament space had
an almost normal width), d) root resorption: combined
linear heights of distinct resorption lacunae on the
planed root (millimetres), e) ankylosis: combined linear
heights of ankylotic union between the regenerated alveolar
bone and the planed root (millimetres). The histometric eval-
uation was carried out under×25 magnification. The apical
border of the notch or the apical extension of instrumentation
(in the absence of a visible notch) was used as the landmark
for the histomorphometric measurements.
Results
Baseline characteristics
All six patients completed the study. The mean age was 44.7±
14.2 years. Distribution of treated sites and the recorded
parameters are shown in Table 1. All six defects displayed a
combined one- and two-wall configuration.
Clinical outcomes
Postoperative healing was uneventful in all cases. Neither
adverse events nor complications such as allergic reactions,
infections, ulcerations or abscesses were detected. No exfo-
liation of the nano-HA paste through the sulcus was ob-
served in any of the cases.
At 7 months following surgery, mean PPD reduction and
mean CAL gain measured 4.0±0.8 and 2.5±0.8 mm,
respectively.
Fig. 1 a Mesial aspect of tooth 34 prior to surgery with OFD+nano-
HA depicting a probing depth of 10 mm (defect No. 2 from Table 1). b
Preoperative radiograph demonstrating the presence of a deep intrab-
ony defect. c Following removal of granulation tissue and thorough
scaling and root planing, the intraoperative situation revealed a deep
one- and two-wall intrabony defect. d The intrabony component was
filled with nano-HA. e At 7 months following surgery, a substantial
reduction of probing depth was measured. f At 7 months, the intraoral
radiograph revealed a hard tissue fill of the intrabony component. g
Removed biopsy. h Complete flap closure, immediately after biopsy
removal. i The histological evaluation revealed a healing predomi-
nantly characterized by a long junctional epithelium and limited re-
generation of cementum and bone. Red arrowhead: coronal extension
of new cementum, blue arrowhead: coronal extension of new bone, red
dotted line: apical extension of the notch. Original magnification×5. k
Higher magnification of the defect shown in i. Formation of new
cementum (NC) and new periodontal ligament (PDL) was confined to
the area of the notch. Red arrowhead: coronal extension of new
cementum, red dotted line: apical extension of the notch, white dotted
line: margin between the newly formed bone and old bone, red aster-
isk: artifact. Original magnification×25
Table 1 Clinical and histological results (expressed in mm) following treatment of intrabony defects with OFD and nano-HA












Diff. Preoperative After 7
months
Diff. Preoperative After 7
months
1 11 11 6 5 2 4 2 13 10 3 4 0 0
2 34 10 6 4 1 3 2 11 9 2 4 0.86 0.86
3 47 10 7 3 5 4 1 15 11 4 4 0 0
4 41 8 3 5 3 6 3 11 9 2 3 0.53 1.02
5 34 6 3 3 5 6 1 11 9 2 3 0.79 1.33
6 11 7 3 4 5 7 2 12 10 2 3 0 0
Mean 8.7 4.7 4.0 3.5 5.0 1.8 12.2 9.7 2.5 3.5 0.4 0.5
SD (±) 1.8 1.7 0.8 1.6 1.4 0.7 1.5 0.7 0.8 0.5 0.4 0.6
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Histological outcomes
The histological analysis revealed that in three out of the six
defects, the healing occurred through formation of a long
junctional epithelium along the debrided root surfaces
extending until the most apical part of the defects. Neither
ankylosis nor root resorption was observed in any of the
biopsies. Limited formation of cementum, periodontal liga-
ment and bone was found in three out of the six biopsies and
was confined to the apical part of the defects (Figs. 1i, k and
2a, b). In two out of the six biopsies, some remnants of the
grafting material were observed (Fig. 2b). The particles
were predominantly surrounded by connective tissue, with-
out signs indicating a potential to promote periodontal or
bone regeneration.
Discussion
The main focus of the present investigation was to provide
histological insight on the potential of nano-HA to promote
periodontal wound healing/regeneration in human intrabony
defects. In all six cases, a substantial reduction of probing
pocket depth and gain of clinical attachment was measured
at 7 months following surgery (i.e. mean PPD reduction of
4.0 mm and mean CAL gain of 2.5 mm). The observation
that no adverse reactions such as allergies or abscesses
occurred in any of the patients indicates that the used graft-
ing material is biocompatible and well tolerated, thus cor-
roborating findings from previous reports [20–27].
The histological evaluation has, however, indicated that
in all six biopsies the healing was predominantly character-
ized by formation of a long junctional epithelium along the
debrided root surfaces, while some limited periodontal re-
generation was only observed in three out of the six defects.
In those three cases, formation of cementum, periodontal
ligament and bone was confined to the apical portion of the
defects. Remnants of the grafting material encapsulated in
connective tissue without apparent signs of bone formation
were detected in two out of the six biopsies, thus indicating
that the material is resorbable but has no visible effect on
enhancing periodontal regeneration.
The clinical findings are comparable to those reported in
two randomized controlled studies [26, 27]. In a first ran-
domized controlled clinical study comparing treatment of
intrabony defects with OFD and nano-HA to OFD alone, the
additional application of the grafting material yielded a
mean PPD reduction of 3.9 mm and a mean CAL gain of
3.6 mm compared to 2.6 mm and 1.8 mm following OFD
alone [26]. A subsequent study has evaluated in intrabony
defects the clinical performance of papilla preservation flap
surgery with or without the application of nano-HA [27]. At
Fig. 2 a Representative photomicrograph revealing limited peri-
odontal regeneration (case 5 from Table 1). Red dotted line: apical
extension of the notch, red arrowhead: coronal extension of new
cementum, blue arrowhead: coronal extension of new bone. Orig-
inal magnification×25. b Higher magnification of the defect
shown in a. Formation of new cementum (NC), new periodontal
ligament (PDL) and new bone (B) was confined to the area of the
notch. Red arrowhead: coronal extension of new cementum, red
dotted line: apical extension of the notch, white dotted line:
margin between the newly formed bone and old bone, red aster-
isk: artefact, white asterisk: remnant nano-HA particle encapsulat-
ed in connective tissue. Original magnification×50
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6 months after surgery, both treatments yielded significant
improvements compared to the baseline defects filled with
nano-HA yielding statistically significantly higher mean PPD
reduction (4.3±1.6 mm) and mean probing bone level gain
(4.3±1.4 mm) compared to the non-filled ones (i.e. 2.9±1.1
and 2.6±1.4 mm, respectively).
The PPD changes reported in the two aforementioned
studies compare well to those obtained in the present one
(i.e. 4.0 mm versus 3.9 and 4.3 mm, respectively). A possi-
ble explanation for the slight discrepancies in terms of CAL
gain may be related to differences in defect configuration
(i.e. in the present study the majority of the defects dis-
played a predominantly one- and two-wall configuration
while in the mentioned ones the great majority of the defects
had either a two-wall or a three-wall configuration. It is well
known that three-walled defects have a significantly higher
healing potential compared to the more complicated one-
walled ones [31–33]. Nevertheless, it should be kept in mind
that neither clinical nor radiographical evaluation is ade-
quate means to demonstrate periodontal regeneration [34].
It has been extensively demonstrated that positive clinical
outcomes such as PPD reduction, CAL gain or defect fill
may not necessarily represent a regenerative type of healing
[13–18, 34]. This is especially evident when analyzing the
literature on human histological studies on intrabony defects
filled with various types of alloplastic materials suggesting
that in the great majority of the defects grafted with these
materials, the healing occurred through a long junctional
epithelium and connective tissue encapsulation of the
graft particles, and limited to no periodontal regeneration
[13–19]. Thus, the present findings corroborate the
results from the mentioned human histological studies
and provide further evidence on the limited biological
value of using alloplastic materials alone to promote
periodontal regeneration.
Another important aspect which needs to be addressed
when interpreting the present findings is related to one of the
inherent weaknesses associated with human histology stud-
ies and namely that, for obvious ethical reasons, only the
less successful cases can be removed as biopsy specimens.
Typically teeth that have been saved (based on clinical
outcome) by a periodontal regenerative procedure are usu-
ally retained according to the patient’s wishes [35]. There-
fore, the sometimes inconsistent findings of periodontal
regeneration may be also related to the histological evalua-
tion of “hopeless” cases. All teeth selected for this study
displayed very advanced destruction of the periodontal sup-
porting apparatus, which may have limited their regenera-
tive potential. In the present study, only a limited number of
defects have been evaluated, and a control group is lacking.
Undoubtedly, it would have been better to include more
defects and also a control group treated with open flap
alone. However, it should be kept in mind that due to the
aforementioned selection criteria, only certain carefully se-
lected defects, can be considered as potential candidates for
a human histological study, thus minimizing the possibility
to find sufficient patients serving as test and control groups
allowing for an adequate statistical analysis. On the other
hand, previous studies performed in similarly advanced
cases have provided evidence for periodontal regeneration
following the use of an enamel matrix derivative or guided
tissue regeneration with and without the use of various types
of grating materials [19, 35–40]. Therefore, it is important to
emphasize that histological evidence of periodontal regen-
eration provides strong proof of principle, even if inconsis-
tency is observed in the outcomes.
In conclusion, within their limits, the present results
indicate that the used nano-HA has limited potential to
promote periodontal regeneration in human intrabony
defects.
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